Reading Time: < 1 minute

–(BUSINESS WIRE)–#NGS–Miroculus has developed a novel digital microfluidics technology to automate and miniaturize genomic protocols such as NGS library prep, synthetic biology, cell editing, and combinatorial chemistry, in a compact, user-friendly system. Our vision is to make the most complex protocols easy and accessible to scientists everywhere.

Company:         Miroculus
 
Headquarters Address: 458 Brannan St.
San Francisco, CA 94107
 
Main Telephone: 4152870505
 
Website:

miroculus.com

 
Type of Organization: Private
 
Industry: Research & Science
 
Key Executives: CEO: Alejandro Tocigl
CCO: Adam Lowe
 
Public Relations
Contact: Adam Lowe
Phone:

4158672326

Email:

[email protected]

 
Investor Relations
Contact: Alejandro Tocigl
Phone:

4157708089

Email:

[email protected]